Ironwood Pharmaceuticals

Yahoo Finance • 4 days ago

Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential

Sarissa Capital Management established a new position in Biohaven Ltd.(NYSE:BHVN) during the fourth quarter, acquiring 513,184 shares worth $5.79 million at quarter’s end, according to a February 17, 2026, SEC filing. What happened Accor... Full story

Yahoo Finance • 9 days ago

Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility

[Black Bull and Bear] peterschreiber.media/iStock via Getty Images Small-cap outperformance has narrowed over the last couple of weeks as investor caution increased, with volatility and geopolitical risk weighing on risk appetite and narr... Full story

Yahoo Finance • 30 days ago

Ironwood Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary

Ironwood Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Delivered 11% LINZESS prescription demand growth in 2025, maintaining a 45% market share despite net price erosion from Medic... Full story

Yahoo Finance • 30 days ago

Ironwood (IRWD) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Feb. 25, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Tom McCourt Chief Medical Officer — Michael Shetzline Chief Financial Officer — Greg Martini Chief Commercial Offi... Full story

Yahoo Finance • 2 months ago

Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is one of the cheap hot stocks to invest in right now. On January 5, Craig-Hallum upgraded Ironwood to Buy from Hold and increased the price target to $5.70 from $3.80. On the same day, Citizens... Full story

Yahoo Finance • 2 months ago

Cheap high flyer healthcare stocks - high momentum and low valuation

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As earnings season ramps up and geopolitical tensions keep affecting the markets, below is a list of the top 10 heal... Full story

Yahoo Finance • 4 months ago

Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations

We recently published 10 Small Stocks with Mighty Gains. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is one of the top-performing stocks on Wednesday. Ironwood Pharmaceuticals soared by 23.32 percent on Wednesday to end at $3.86 apiece a... Full story

Yahoo Finance • 5 months ago

Ironwood surges after Q3 beat; raised outlook for AbbVie-partnered Linzess

[$10 Banknote Stacking, Green Up Arrow Rise] spawns Shares of Ironwood Pharmaceuticals (IRWD [https://seekingalpha.com/symbol/IRWD]) climbed ~34% on Monday after the company well exceeded Street forecasts with its Q3 2025 financials and h... Full story

Yahoo Finance • 7 months ago

Wondering what's happening in today's after-hours session?

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE COMMENT DHAI [https://www.chartmill.com/stock/quote/DHAI/profile... Full story

Yahoo Finance • 8 months ago

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Reports Strong Q2 2025 Earnings with 37.5% Revenue Beat and 250% EPS Surge

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD [https://www.chartmill.com/stock/quote/IRWD]) reported its second-quarter 2025 results, delivering a significant earnings beat driven by strong performance of its flagship product LINZESS and progr... Full story

Yahoo Finance • 9 months ago

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) announced that its Audit Committee has dismissed Ernst & Young LLP (EY) as its independent registered public accounting firm. The decision was made on July 3 after the committee solicited and re... Full story

Yahoo Finance • 12 months ago

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday?

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) stands against other stocks that fall behind amid market optimism... Full story

Yahoo Finance • 2 years ago

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

– Expects high-single digit percentage LINZESS® EUTRx prescription demand growth in 2024 – – Expects 2024 adjusted EBITDA of greater than $150 million – BOSTON, January 08, 2024--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: I... Full story

Yahoo Finance • 2 years ago

Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio

BOSTON, December 12, 2023--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced the successful completion of the squeeze-out merger under Swiss law (the "Squeeze-Out... Full story

Yahoo Finance • 3 years ago

15 Small Innovative Companies According to the Media

In this piece, we will take a look at the fifteen small innovative companies according to the media. For more small and innovative companies, head on over to 5 Small Innovative Companies According to the Media. Innovation is the bedrock o... Full story

Yahoo Finance • 3 years ago

12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds

In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Most Undervalued Pharma Stocks To Buy According To Hedge Funds. Fitch Ratings has... Full story

Yahoo Finance • 3 years ago

Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance

– sNDA submitted to U.S. FDA in December 2022 seeking approval of a new indication of LINZESS® (linaclotide) for functional constipation in children and adolescents 6 to 17 years of age – – Expects high single-digit LINZESS® EUTRx prescri... Full story

Yahoo Finance • 3 years ago

Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

BOSTON, January 04, 2023--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesda... Full story

Yahoo Finance • 4 years ago

Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600

NEW YORK, June 3, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices: VICI Properties Inc. (NYSE:VICI) will replace Cerner Corp. (NASD: CERN)... Full story